Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inovio Pharmaceuticals (GB:0A43)
LSE:0A43
RESEARCH TOOLSreports
Inovio Pharmaceuticals (0A43) Share Price & Analysis
2 Followers
0A43 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.91 - $14.60
Previous Close$10.49
Volume2.74K
Average Volume (3M)8.23K
Market Cap
$268.65M
Enterprise Value$153.57M
Total Cash (Recent Filing)$145.29M
Total Debt (Recent Filing)$30.21M
Price to Earnings (P/E)N/A
Beta1.90
Next Earnings
May 08, 2024EPS Estimate
-$0.99Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,370,365
10 Day Avg. Volume4,765
30 Day Avg. Volume8,228
Standard Deviation0.29
R-Squared0.07
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)2.19
Price to Sales (P/S)239.32
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue184.56
Enterprise Value/Gross Profit184.57
Enterprise Value/Ebitda-1.57
Forecast
1Y Price Target
$11.00Price Target Upside4.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Inovio Pharmaceuticals News
0A43 FAQ
What was Inovio Pharmaceuticals’s price range in the past 12 months?
Inovio Pharmaceuticals lowest share price was $3.90 and its highest was $14.60 in the past 12 months.
What is Inovio Pharmaceuticals’s market cap?
Currently, no data Available
When is Inovio Pharmaceuticals’s upcoming earnings report date?
Inovio Pharmaceuticals’s upcoming earnings report date is May 08, 2024 which is in 13 days.
How were Inovio Pharmaceuticals’s earnings last quarter?
Inovio Pharmaceuticals released its earnings results on Mar 06, 2024. The company reported -$1.1 earnings per share for the quarter, beating the consensus estimate of -$1.186 by $0.086.
Is Inovio Pharmaceuticals overvalued?
According to Wall Street analysts Inovio Pharmaceuticals’s price is currently Undervalued.
Does Inovio Pharmaceuticals pay dividends?
Inovio Pharmaceuticals does not currently pay dividends.
What is Inovio Pharmaceuticals’s EPS estimate?
Inovio Pharmaceuticals’s EPS estimate is -$0.99.
How many shares outstanding does Inovio Pharmaceuticals have?
Inovio Pharmaceuticals has 25,906,624 shares outstanding.
What happened to Inovio Pharmaceuticals’s price movement after its last earnings report?
Inovio Pharmaceuticals reported an EPS of -$1.1 in its last earnings report, beating expectations of -$1.186. Following the earnings report the stock price went down -11.676%.
Which hedge fund is a major shareholder of Inovio Pharmaceuticals?
Among the largest hedge funds holding Inovio Pharmaceuticals’s share is GMT Capital Corp. It holds Inovio Pharmaceuticals’s shares valued at N/A.
---
Inovio Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (4.86% Upside)
$11.00 (4.86% Upside)
Blogger Sentiment
Bullish
GB:0A43 Sentiment 87%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.29%
12-Months-Change
Fundamentals
Return on Equity
-79.55%
Trailing 12-Months
Asset Growth
-50.71%
Trailing 12-Months
Company Description
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
---
0A43 Earnings Call
Q4 2024
0:00 / 0:00
---
0A43 Stock 12 Months Forecast
Average Price Target
$11.00
▲(4.86% Upside)
Technical Analysis
Best Analysts Covering 0A43
1 Year
1 Year Success Rate
1/8 ratings generated profit
1 Year Average Return
-53.01%
upgraded a buy rating 3 months ago
Copying Hartaj Singh's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -53.01% per trade.
---